1. Thomas OW. Recurrent erosion. Tr Am Ophth Soc. 1984; 82:850–98.
2. Suh Y, Kim MS. The longterm evaluation of recurrent corneal erosion. J Korean Ophthalmol Soc. 2002; 43:1570–6.
3. Diez-Feijóo E, Grau AE, Abusleme EI, Durán JA. Clinical presentation and causes of recurrent corneal erosion syndrome: review of 100 patients. Cornea. 2014; 33:571–5.
4. Lee SH, Kim TI, Chung SH, et al. A case of combined bacterial keratitis with recurrent corneal erosion. J Korean Ophthalmol Soc. 2007; 48:449–54.
5. Reeves SW, Kang PC, Zlogar DF, et al. Recurrent corneal erosion syndrome: a study of 364 episodes. Ophthalmic Surg Lasers Imaging. 2010; Mar 9. 1–2. doi: 10.3928/15428877-20100215-44. [Epub ahead of print].
Article
6. Diez-Feijóo E, Durán JA. Optical coherence tomography findings in recurrent corneal erosion syndrome. Cornea. 2015; 34:290–5.
Article
7. Sakimoto T, Shoji J, Yamada A, Sawa M. Upregulation of matrix metalloproteinase in tear fluid of patients with recurrent corneal erosion. Jpn J Ophthalmol. 2007; 51:343–6.
Article
8. Kameishi S, Sugiyama H, Yamato M, et al. Remodeling of epithelial cells and basement membranes in a corneal deficiency model long-term follow-up. Lab Invest. 2015; 95:168–79.
9. Eke T, Morrison DA, Austin DJ. Recurrent symptoms following traumatic corneal abrasion: prevalence, severity, and the effect of a simple regimen of prophylaxis. Eye (Lond). 1999; 13(Pt 3a):345–7.
Article
10. Ewald M, Hammersmith KM. Review of diagnosis and management of recurrent erosion syndrome. Curr Opin Ophthalmol. 2009; 20:287–91.
Article
11. Dursun D, Kim MC, Solomon A, Pflugfelder SC. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix met-alloproteinase-9, doxycycline and corticosteroids. Am J Ophthalmol. 2001; 132:8–13.
Article
12. Wang L, Tsang H, Coroneo M. Treatment of recurrent corneal erosion syndrome using the combination of oral doxycycline and topical corticosteroid. Clin Experiment Ophthalmol. 2008; 36:8–12.
Article
13. Ziakas NG, Boboridis KG, Terzidou C, et al. Long-term follow up of autologous serum treatment for recurrent corneal erosions. Clin Experiment Ophthalmol. 2010; 38:683–7.
Article
14. Yoon KC, Choi W, You IC, Choi J. Application of umbilical cord serum eyedrops for recurrent corneal erosions. Cornea. 2011; 30:744–8.
Article
15. Moutray TN, Frazer DG, Jackson AJ. Recurrent erosion syndrome–the patient's perspective. Cont Lens Anterior Eye. 2011; 34:139–43.
16. Fraunfelder FW, Cabezas M. Treatment of recurrent corneal erosion by extended-wear bandage contact lens. Cornea. 2011; 30:164–6.
Article
17. Ahad MA, Anandan M, Tah V, et al. Randomized controlled study of ocular lubrication versus bandage contact lens in the primary treatment of recurrent corneal erosion syndrome. Cornea. 2013; 32:1311–4.
Article
18. Singh RP, Raj D, Pherwani A, et al. Alcohol delamination of the corneal epithelium for recalcitrant recurrent corneal erosion syndrome: a prospective study of efficacy and safety. Br J Ophthalmol. 2007; 91:908–11.
Article
19. Ryan G, Lee GA, Maccheron L. Epithelial debridement with diamond burr superficial keratectomy for the treatment of recurrent corneal erosion. Clin Experiment Ophthalmol. 2013; 41:621–2.
Article
20. Avni Zauberman N, Artornsombudh P, Elbaz U, et al. Anterior stromal puncture for the treatment of recurrent corneal erosion syndrome: patient clinical features and outcomes. Am J Ophthalmol. 2014; 157:273–9.e1.
Article
21. Tsai TY, Tsai TH, Hu FR, et al. Recurrent corneal erosions treated with anterior stromal puncture by neodymium: yttrium-aluminum-garnet laser. Ophthalmology. 2009; 116:1296–300.
Article
22. Kim SY, Ko BY. Evaluaion of anterior stromal puncture using Nd: YAG laser for refractory recurrent corneal erosion. J Korean Ophthalmol Soc. 2015; 56:331–8.
23. Choi M, Jung JW, Seo KY, et al. Comparison of Nd: YAG laser versus conservative management in the treatment of recurrent corneal erosion. J Korean Ophthalmol Soc. 2015; 56:687–93.
24. Ko BY, Lee GW. Clinical results of phototherapeutic keratectomy for refractory recurrent corneal erosion. J Korean Ophthalmol Soc. 2011; 52:392–400.
Article
25. Kim JC, Tseng SC. Transplantation of preserved human amniotic membrane for surface reconstruction in severely damaged rabbit corneas. Cornea. 1995; 14:473–84.
Article
26. Lee KH, Lee DW, Kim IC. The clinical effect of amniotic membrane transplantation for various ocular surface diseases. J Korean Ophthalmol Soc. 2007; 48:7–12.
27. Malhotra C, Jain AK. Human amniotic membrane transplantation: different modalities of its use in ophthalmology. World J Transplant. 2014; 4:111–21.
Article
28. Koizumi NJ, Inatomi TJ, Sotozono CJ, et al. Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res. 2000; 20:173–7.
Article
29. Fukuda K, Chikama T, Nakamura M, Nishida T. Differential distribution of subchains of the basement membrane components type IV collagen and laminin among the amniotic membrane, cornea, and conjunctiva. Cornea. 1999; 18:73–9.
Article
30. Meller D, Pires RT, Mack RJ, et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology. 2000; 107:980–9. discussion 990.
Article
31. Lee HS, Oh HJ, Yoon KC. Phototherapeutic keratectomy with or without amniotic membrane transplantation for symptomatic bullous keratopathy. J Korean Ophthalmol Soc. 2013; 54:1180–6.
Article
32. Yeom HY, Park SB, Lee HK, Kim EK. Effects of amniotic membrane after LASEK on epithelial healing, clinical and refractive outcomes. J Korean Ophthalmol Soc. 2004; 45:195–202.